BIOTECHNOLOGY VALUE FUND L P
SEC CIK 918923 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| GPCR | Structure Therapeutics Inc. | See explanation of responses | 0 | — | — | 1 | 2023-05-10 | 2023-05-10 |
| CGEM | Cullinan Therapeutics, Inc. | See Explanation of Responses | 4.06M | $8.27M | — | 1 | 2022-06-01 | 2022-06-01 |
| KYMR | Kymera Therapeutics, Inc. | See Explanation of Responses | 2.04M | $25.72M | — | 2 | 2021-07-01 | 2022-05-20 |
| OLMA | Olema Pharmaceuticals, Inc. | See Explanation of Responses | 471.4K | $6.95M | — | 1 | 2021-11-30 | 2021-11-30 |
Most active insiders at GPCR, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Berrios John Joseph | Chief Commercial Off | — | — |
| 2 | Coll Crespo Blas | Chief MEDICAL Off | — | — |
| 3 | Ma Yingli | CTO | — | — |
| 4 | Lin Xichen | CSO | — | — |
| 5 | Yoon Jun | CFO | — | — |
| 6 | Hall Ashley | Chief Development Off | — | — |
| 7 | Lang Matthew | COO, GC | — | — |
| 8 | Stevens Raymond C | CEO, Dir | — | — |
BIOTECHNOLOGY VALUE FUND L P made no open-market trades at GPCR in the last 12 months.
Transactions 5
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-05-12 | 2023-05-10 | GPCR | Structure Therapeutics Inc. | BIOTECHNOLOGY VALUE FUND L P | See explanation of responses | J - Other | — | -7.41M | 0 | -100% | — |
| M | 2022-06-03 | 2022-06-01 | CGEM | Cullinan Therapeutics, Inc. | BIOTECHNOLOGY VALUE FUND L P | See Explanation of Responses | P - Purchase | $11.00 | +751.4K | 4.06M | +23% | +$8.27M |
| M | 2022-05-24 | 2022-05-20 | KYMR | Kymera Therapeutics, Inc. | BIOTECHNOLOGY VALUE FUND L P | Dir, See Remarks, Footnotes | P - Purchase | $14.00 | +10.1K | 2.04M | +0.5% | +$141.4K |
| M | 2021-12-02 | 2021-11-30 | OLMA | Olema Pharmaceuticals, Inc. | BIOTECHNOLOGY VALUE FUND L P | See Explanation of Responses | P - Purchase | $9.39 | +739.7K | 471.4K | New | +$6.95M |
| M | 2021-07-06 | 2021-07-01 | KYMR | Kymera Therapeutics, Inc. | BIOTECHNOLOGY VALUE FUND L P | See Explanation of Responses | P - Purchase | $47.00 | +544.2K | 208.5K | New | +$25.58M |
Purchase Sale Sale after option exercise All abbreviations